Literature DB >> 7191035

Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats.

B H Herman, F Leslie, A Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7191035     DOI： 10.1016/0024-3205(80)90084-3

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  8 in total

Review 1.  Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

Authors:  V K Shukla; S Lemaire
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

2.  Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.

Authors:  Georgy Bakalkin; Hiroyuki Watanabe; Justyna Jezierska; Cloë Depoorter; Corien Verschuuren-Bemelmans; Igor Bazov; Konstantin A Artemenko; Tatjana Yakovleva; Dennis Dooijes; Bart P C Van de Warrenburg; Roman A Zubarev; Berry Kremer; Pamela E Knapp; Kurt F Hauser; Cisca Wijmenga; Fred Nyberg; Richard J Sinke; Dineke S Verbeek
Journal:  Am J Hum Genet       Date:  2010-10-28       Impact factor: 11.025

3.  Specific receptor for the opioid peptide dynorphin: structure--activity relationships.

Authors:  C Chavkin; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

4.  A direct chemical interaction between dynorphin and excitatory amino acids.

Authors:  A Woods; A Zangen
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

5.  Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.

Authors:  G T Shearman; R Schulz; P W Schiller; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Sequence and expression of the rat prodynorphin gene.

Authors:  O Civelli; J Douglass; A Goldstein; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).

Authors:  M Ukai; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Cerebellar developmental deficits underlie neurodegenerative disorder spinocerebellar ataxia type 23.

Authors:  Cleo J L M Smeets; Kai Yu Ma; Simon E Fisher; Dineke S Verbeek
Journal:  Brain Pathol       Date:  2020-11-02       Impact factor: 6.508
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.